BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7650331)

  • 1. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group.
    Livraghi T; Bolondi L; Buscarini L; Cottone M; Mazziotti A; Morabito A; Torzilli G
    J Hepatol; 1995 May; 22(5):522-6. PubMed ID: 7650331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group.
    Orlando A; Cottone M; Virdone R; Parisi P; Sciarrino E; Maringhini A; Caltagirone M; Simonetti RG; Pagliaro L
    Scand J Gastroenterol; 1997 Jun; 32(6):598-603. PubMed ID: 9200294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
    Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
    Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
    Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis.
    Gournay J; Tchuenbou J; Richou C; Masliah C; Lerat F; Dupas B; Martin T; Nouel JF; Schnée M; Montigny P; D'Alincourt A; Hamy A; Paineau J; Le Néel JC; Le Borgne J; Galmiche JP
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1529-38. PubMed ID: 12182753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.
    Savastano S; Miotto D; Casarrubea G; Teso S; Chiesura-Corona M; Feltrin GP
    J Clin Gastroenterol; 1999 Jun; 28(4):334-40. PubMed ID: 10372931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?
    Farinati F; Gianni S; Marin G; Fagiuoli S; Rinaldi M; Naccarato R
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1217-24. PubMed ID: 11711779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial.
    Giorgio A; Di Sarno A; De Stefano G; Scognamiglio U; Farella N; Mariniello A; Esposito V; Coppola C; Giorgio V
    Anticancer Res; 2011 Jun; 31(6):2291-5. PubMed ID: 21737654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.
    Castells A; Bruix J; Bru C; Fuster J; Vilana R; Navasa M; Ayuso C; Boix L; Visa J; Rodés J
    Hepatology; 1993 Nov; 18(5):1121-6. PubMed ID: 8225217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
    Cioni G; Turrini F; Pedrazzini PG; Cristani A; Ventura E; Ferrari A; D'Alimonte P; Ariosi P; De Santis M
    Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
    Castellano L; Calandra M; Del Vecchio Blanco C; de Sio I
    J Hepatol; 1997 Nov; 27(5):862-70. PubMed ID: 9382974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.
    Li YH; Wang CS; Liao LY; Wang CK; Shih LS; Chen RC; Chen PH
    J Formos Med Assoc; 2003 Mar; 102(3):141-6. PubMed ID: 12783129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience.
    Lencioni R; Pinto F; Armillotta N; Bassi AM; Moretti M; Di Giulio M; Marchi S; Uliana M; Della Capanna S; Lencioni M; Bartolozzi C
    Eur Radiol; 1997; 7(4):514-9. PubMed ID: 9204330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
    Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
    J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients.
    Giorgio A; Tarantino L; Mariniello N; de Stefano G; Perrotta A; Aloisio V; Voza A; Finizia L; Alaia A; Del Viscovo L
    Eur J Ultrasound; 1998 Dec; 8(3):201-6. PubMed ID: 9971904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.